What one share of Ceribell holds
We are a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting.
Ceribell’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.73 |
|---|---|
| Profit | −$1.76 |
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$1.46 |
| Cash and investments | $3.38 |
| Debt | $0.52 |
| Book value | $3.36 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $8.53 | −$5.56 | $0.19 | −$5.68 | — | −$20.67 |
| 2024 | $5.48 | −$3.39 | $0.11 | −$3.04 | — | — |
| 2025 | $2.44 | −$1.46 | $0.02 | −$1.14 | — | $4.14 |
Common questions about Ceribell
How much does one share of Ceribell earn?
Over the last 12 months, Ceribell lost $1.76 for each share on $2.73 of sales.
Does Ceribell pay a dividend?
Ceribell didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Ceribell’s book value per share?
Ceribell’s book value is $3.36 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Ceribell have?
Each share of Ceribell has $3.38 of cash and investments and $0.52 of debt, as of June 30, 2026.
What is Ceribell’s free cash flow per share?
−$1.46 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.